Top Markets
#1 Derive Derive +33.58%
#2 Cross Cross +17.15%
#3 The Bitcoin Bull The Bitcoin Bull +14.40%
#4 Palladium Network Palladium Network +12.35%
#5 Geodnet Geodnet +10.37%
#6 Gama Token Gama Token +9.18%
#7 Audiera Audiera +9.15%
#8 Biconomy Biconomy +8.21%
#9 Velvet Velvet +7.83%
#10 Humanity Humanity +7.73%
Coin of the day
Derive Derive
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
National Graphite Corp. National Graphite Corp.

National Graphite Corp.

NGRC
Rang in Aktien #35948
National Graphite Corp. (NGRC), operating through its subsidiary Biotech... National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Aktienkurs
$0.021
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$3.24M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-46.15%
Land
US
Handel National Graphite Corp. (NGRC)

Kategorie

Financial Services
Kursverlauf für National Graphite Corp. (NGRC)
Höchster Schlusskurs: $0.02 am 2026-08-01

Niedrigster Schlusskurs: $13.33 am 2012-08-01
Kursverlauf der Aktie von National Graphite Corp. von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 43.77%
2025 -40.77%
2024 -34.87%
2023 -38.75%
2022 -23.26%
2021 160.93%
2020 52.70%
2019 -17.60%
2018 -16.56%
2017 -18.16%
2016 -36.30%
2015 -74.52%
2014 -34.53%
2013 -95.88%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 $300.00 0.00%
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 $2.65 0.00%
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 $22.70 0.00%
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 $7.39 0.00%
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 $49.95 0.00%
US